Good morning, good lookin'. Apple, Merck, and Burger King earnings, plus some economic data, moved the Dow down one point yesterday.
Heady valuations, increasing competition, and pre-earnings anxiety hit Monday's three worst stocks
Why did shares of Dow component Merck drop as other drugmakers, such as Bristol-Myers Squibb and AstraZeneca, rose today?
After Merck's profits nosedive by 35% for the quarter, Pfizer investors look ahead to the company's own quarterly report tomorrow
Dow component Pfizer reports its earnings tomorrow, following earlier results from Merck and Johnson & Johnson. What Pfizer says could have a big impact on the Dow Jones Industrial Average.
Merck's stock has been stuck in neutral over the past year, but will this company be able to evade the worst of the patent cliff's hits?
The Dow Jones Industrial Average is getting held back by weak earnings from Merck and drops in Boeing and Microsoft as well.
This pharma can't seem to find its groove.
Why Apple, Merck, and Burger King will be on the move today.
Merck managed to beat expectations, but total sales fell 4% and adjusted net income declined 7%.